Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 17, 2008

Premium
Daniel Nevrivy, a Washington, DC, patent attorney, has launched Nevrivy Patent Law Group, a law firm focused on biotechnology and pharmaceutical patent law for businesses, universities, and inventors.
 
The new firm will be located in the Georgetown area of Washington, DC. Nevrivy was formerly with the DC firm of Sterne, Kessler, Goldstein, and Fox for seven years. He holds a PhD in molecular and cellular biology.
 
Nevrivy said in a statement that he is currently building a team of lawyer-scientists to “serve businesses, universities, and inventors who seek innovative ways to lower their costs for protection of their own IP without sacrificing quality.”
 

 
The Association of University Research Parks last week elected Gregory Deason, director of the Purdue Research Park, as president of the organization.
 
Deason’s appointment was announced at AURP’s annual meeting in St. Petersburg, Fla.
 
In addition, AURP elected four new members and re-elected two individuals to its board of directors.
 
The new members are Kevin Bryne, chief investment officer with the University Financing Foundation in Atlanta; Reynold Gonzales, director of technology transfer at the Institute of Innovation and Technology Transfer of Nuevo Leon, Mexico, and director of the Parque de Investgacion e Innovacion Tecnnologica; Marcia Mellitz, president and CEO of the Center for Emerging Technologies in St. Louis, Mo.; and Scott Pickard, manager of Research Park and Incubation Facilities for the University of Illinois in Champaign.
 
The re-elected board members are Brian Darmondy, associate vice president of research and economic development at the University of Maryland; and Teresa McKnight, CEO of the South Dakota State University Growth Partnership and executive director of the South Dakota State University Innovation Campus.
 

 
The Foundation for the National Institutes of Health said last week that it has named five new directors: Anne Wojcicki, co-founder of 23andMe; Pfizer Chief Medical Officer Joseph Feczko; Peter Neupert, corporate vice president of the Health Solutions Group at Microsoft; Kurt Schmoke, dean of Howard University School of Law; and Samuel Thier, professor emeritus, medicine and health care policy at Harvard Medical School and Massachusetts General Hospital.

The appointments were effective as of Nov. 12, 2008.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.